KLK3 and posterior cortical atrophy: They demonstrated that using TZPSAD can improve the efficiency of PSA in PCa diagnosis and avoid unnecessary prostatic biopsies in men with a PSA of both 4.0–10.0 and 10.1–20.0 ng/ml.